Osteoarthritis D010003

Diseases [C] » Musculoskeletal Diseases [C05] » Rheumatic Diseases » Osteoarthritis

Diseases [C] » Musculoskeletal Diseases [C05] » Joint Diseases » Arthritis » Osteoarthritis

Description

A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.   MeSH

Subtype Terms (3)

Osteoarthritis, Hip
63 drugs (41 approved, 22 experimental)

Osteoarthritis, Knee
324 drugs (107 approved, 217 experimental)

Osteoarthritis, Spine
4 drugs (2 approved, 2 experimental)



Organization Involved with Phase 4 Indications (182)

Organization Involved with Phase 3 Indications (235)

Abbott

Achieve Clinical Research, LLC

Acri-Phase I, LLC

AFT Pharmaceuticals, Ltd.

Akorn, Inc.

Alberta Bone and Joint Health Institute

Alliance Clinical Research

Alpharma

Altoona Center for Clinical Research

Alza

Amneal Pharmaceuticals

Ampio Pharmaceuticals. Inc.

Anchen Pharmaceuticals, Inc

Andrews Research & Education Foundation

Anika Therapeutics, Inc.

Apimeds

AppleMed Research, Inc.

Arroyo Medical Group, Inc

Arthritis Treatment Center, Frederick, Maryland

Arthritis Treatment Center, Maryland

ArthroLab Inc.

Atrium Innovations

Avail Clinical Research

Axsome Therapeutics, Inc.

Azidus

Bangkok Drug company

Bangkok Laboratories and Cosmetics

Bayer

Beacon Clinical Research, LLC

BioDelivery Sciences International

Biologische Heilmittel Heel GmbH

Biosplice Therapeutics

Blair Orthopedic Associates, Inc

Bone Therapeutics S.A

CAPRI Clinic

Carbylan Therapeutics, Inc.

Centre de Rhymatologie St-Louis

Centrexion Therapeutics

Cephalon

Charlottesville Medical Research Center, LLC

Chengdu University of Traditional Chinese Medicines

China Medical University

Chonbuk National University

CHU Henri Mondor

Chunang University Hospital

Chungnam National University

Chung Shan Medical University

Clinical Inquest Center Ltd.

Clinical Investigations of Texas, LLC

Clinical Investigation Specialists, Inc

Clinical Research Solutions

Clinical Study Center of Asheville, LLC

Clinical Trial New Zealand

Clinical Trials Technology Inc

Commonwealth Orthopedics

CrystalGenomics, Inc.

Daiichi Sankyo

Department of Veteran Affairs

Drug Studies America

Siloam Hospitals

Singapore General Hospital

Siriraj Hospital

Smerud Medical Research Denmark

Solvay

Sorrento Therapeutics, Inc.

South-Eastern Norway Regional Health Authority

Sponsor GmbH

Srinakharinwirot University

Sristek Clinical Research

Stanford University

Sterling Research Group, Ltd

Sundance Clinical Research, LLC

Suzhou Hospital of Traditional Chinese Medicine

Syarif Hidayatullah State Islamic University

Taisho Pharmaceutical

Taiwan Liposome Company

Takeda

Techfields

Tel Aviv University

Teva

The Cleveland Clinic

The Fourth Central Hospital of Tianjin

The Marcus Foundation

The New England Baptist Hospital

The Physicians' Services Incorporated Foundation

Thomas Jefferson University

Thrombotargets Europe S.L

TissueGene, Inc.

Towson Orthopaedic Associates

TRB Chemedica

Triad Clinical Research

Tucson Orthopaedic Institute

United States Navy

Universal BioPharma Research Inc.

Universidad Catolica Santiago de Guayaquil

Universidad Nacional de Rosario

University Hospital Pellenberg

University of Birmingham

University of California, Los Angeles

University of Florida

University of Illinois at Chicago

University of Nice Sophia Antipolis

University of Paris

University of Toronto

University of Western Ontario

Uzsoki Hospital

Well Pharma Medical Research Corporation

Wells Institute for Health Awareness

Westlake Medical Research

Westside Center for Clinical Research

Winston Laboratories

Wuhan University

Xalud Therapeutics, Inc.

Yeungnam University

Yooyoung Pharmaceutical Co.,Ltd.

Zars Pharma Inc.

Zodiac Produtos Farmaceuticos S.A.

Organization Involved with Phase 2 Indications (207)

Organization Involved with Phase 1 Indications (63)

Organization Involved with Other Experimental Indications (123)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.